Sunshine Lake Pharma Co., Ltd. (SEHK: 6887)
Health Care · Pharmaceuticals · CN
HK$38.50
+6.29% today · -26.0% 1Y
Sunshine Lake Pharma Co., Ltd. (SEHK: 6887) operates in the Pharmaceuticals industry within the Health Care sector. The company is valued at $2.83B and employs 6,353 people.
Over the last twelve months the share price has lost 26.0%, trading between 15.01 and 56.00.
Tweenvest scores Sunshine Lake Pharma Co., Ltd. across four factors: quality 56/100, value 25/100, growth 100/100. Its strongest factor is growth.
6887 price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $2.83B
- Revenue (TTM)
- $688.42M
- P/E
- 62.90
- EPS
- 0.55
- Dividend yield
- —
- Beta (5Y)
- -0.09
- 52-week high
- HK$56.00
- 52-week low
- HK$15.01
- Avg volume (3M)
- —
- Shares outstanding
- 575.35M
- Employees
- 6,353
- Next earnings
- —
About Sunshine Lake Pharma Co., Ltd.
Sunshine Lake Pharma Co., Ltd. operates as a pharmaceutical company. It engages in the research, development, production and commercialization of modified new drugs, generic drugs and biosimilars. The company was founded on December 29, 2003 and is headquartered in Dongguan, China.
- ISIN
- CNE1000070M8
- Founded
- 2001
- Listed since
- Aug 7, 2025
- Exchange
- The Stock Exchange of Hong Kong Ltd.
- Currency
- HKD
Other Pharmaceuticals companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Eli Lilly and CompanyNYSE: LLY | $1.10T | $1,231.78 | -0.15% |
| Johnson & JohnsonNYSE: JNJ | $658.24B | $272.81 | -0.12% |
| Merck & Co., Inc.NYSE: MRK | $385.99B | $155.85 | -0.38% |
| Roche Holding AGSWX: ROP | $371.62B | CHF371.90 | -0.51% |
| Novartis AGSWX: NOVN | $303.81B | CHF128.34 | +1.25% |
| AstraZeneca PLCLSE: AZN | $263.84B | £123.29 | -1.18% |
| Novo Nordisk A/SCPSE: NOVO B | $212.51B | Dkr307.80 | +2.86% |
| Pfizer Inc.NYSE: PFE | $162.84B | $28.51 | -0.21% |
Figures last refreshed Aug 18, 2026.